We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
AUM
$304M
AUM Growth
+$17.2M
Cap. Flow
-$1.31M
Cap. Flow %
-0.43%
Top 10 Hldgs %
39.76%
Holding
80
New
1
Increased
8
Reduced
38
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.66M
2
NVS icon
Novartis
NVS
+$488K
3
GE icon
GE Aerospace
GE
+$177K
4
CVS icon
CVS Health
CVS
+$167K
5
SLB icon
SLB Ltd
SLB
+$90.5K

Sector Composition

Rank Sector Weight
1 Healthcare 27.94%
2 Industrials 23%
3 Technology 16.75%
4 Energy 9.09%
5 Consumer Staples 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ED icon
76
Consolidated Edison
ED
$40.2B
$284K 0.09%
3,344
-1,075
-24% -$92.4K
COLM icon
77
Columbia Sportswear
COLM
$2.93B
$281K 0.09%
3,916
-250
-6% -$16.4K
LEG icon
78
Leggett & Platt
LEG
$1.31B
$263K 0.09%
5,500
SVU
79
DELISTED
SUPERVALU Inc.
SVU
-32,550
Closed -$708K
LVLT
80
DELISTED
Level 3 Communications Inc
LVLT
-5,290
Closed -$282K

Similar funds

Thompson Rubinstein Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Rubinstein Investment Management held 80 positions worth $304M, up 6% from $287M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.8%. Thompson Rubinstein Investment Management opened 1 new position and exited 2, leaving the 80-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q4 2017 buy was Celgene Corp: 14,732 shares worth $1.54M.
  • Thompson Rubinstein Investment Management added most to Novartis in Q4 2017, an estimated $488K increase.
  • Thompson Rubinstein Investment Management's biggest Q4 2017 reduction was Bruker, cutting an estimated $923K.
  • Thompson Rubinstein Investment Management fully exited SUPERVALU Inc. in Q4 2017, selling an estimated $708K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 40% of its $304M portfolio in Q4 2017.
  • Thompson Rubinstein Investment Management opened 1 new position and closed 2 in Q4 2017.
  • Thompson Rubinstein Investment Management's portfolio value rose 6% quarter-over-quarter to $304M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q4 2017, filed 17 Jan 2018.